|
Faculty
FACULTY Dra. Ana Lluch , MD, Spain (Chairman
and moderator). Dr. Cesar Rodríguez, MD, Spain (Co-chairman).
Dra. Laura G. Estévez, MD, Spain. Dr. Álvaro Rodríguez
-Lescure MD, Spain.
On behalf of Dra. Ana Lluch and Dr. Cesar
Rodriguez, co-chairs, we are pleased to invite you to
the Expert Practice in Breast Cancer meeting in Madrid,
Spain. During this case-based meeting, leaders in the
field discuss clinical issues encountered daily with
participants in an interactive format.
Spoken language: Spanish
Topics include:
- Overview of Her 2 family of proteins and Targeted
Therapies
- How long do you use Herceptin – a debate
Discussions include:
- Optimal adjuvant HT for postmenopausal BC pts
- M+ HER2+ pt. What do you give, how long, what do
you do when the patient fail herceptin, would you
change your choice when the patient would had multiple
brain mets?
- Patient with inflammatory BC overexpressing HER2.
What would you give?
- Optimal adjuvant chemotherapy for high risk pre-menopausal
patients with breast cancer
- Endocrine therapy for a postmenopausal patient with
first line metastatic breast cancer after adjuvant
AI’s.
Click
here for more information in Español
|